Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Tectonic Therapeutic Inc

TECX ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: BUY

Last Close

$34.91

▲ +2.74%

Market Cap $682.47M · Vol 29.60K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$682.47M

Small Cap

Div Yield

N/A

EPS Growth

-25.73%

YoY

RSI (14)

62.49

Momentum

Beta

1.31

vs Market

52W High

$38.75

9.91% below

52W Low

$14.40

142.43% above

Volume

29.60K

Avg 56.43K

P/B

1.56

Price-to-book

ROE

N/A

Return on equity

Free Float

60.76%

Public shares

Shariah Compliance8 STANDARDS

✗ Tectonic Therapeutic Inc (TECX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TECX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+12.69%

+0.29%

+17.15%

+56.69%

YTD

+67.35%

+42.66%

+91.39%

-51.27%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-74,151,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-35.23% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	1.56
P/FCF	N/A
EPS Growth	-25.73%
Outstanding Shares	19.55M

Technical Indicators

50-Day SMA	$31.59
200-Day SMA	$26.14
RSI (14)	62.49
Beta	1.31
52-Week High	$38.75
52-Week Low	$14.40

Volume Today	29.60K
Avg Daily Volume (30D)	56.43K
Relative Volume	0.52x
Volatility (10D)	86.84
Volatility (30D)	72.10
Free Float	60.76%

Analyst Consensus

BUY

Current Price $34.91

Mean Target $77.56

52W Low$14.40 52W High$38.75

Current

Target

$14.40 $38.75

Current Analyst target

+122.16% upside potential · 9 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00DJ4T7F9

ISINUS8789721086

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Its product candidates are TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. Its second development candidate, TX2100, is a VHH-Fc fusion antagonist antibody that binds to the APJ receptor (APLNR), also known as the apelin receptor. Its APJ is a differentiated approach for the treatment of hereditary hemorrhagic telangiectasia (HHT) and is a selective anti-angiogenic target that is primarily expressed in endothelial cells.